期刊文献+

神经生长因子低亲和力受体(p75NTR)的模拟配基的筛选 被引量:2

Phage Display Peptide Library Selection on Whole Cells Yields Peptides Specific for NGF Receptor p75NTR
下载PDF
导出
摘要 人神经生长因子低亲和力受体 (p75NTR)转染R2细胞而建立的R2L1细胞 ,在去血清培养时发生凋亡 ,该作用可被神经生长因子 (NGF)所抑制 .用R2L1和R2两种细胞差式筛选噬菌体随机 7肽库和 1 2肽库 ,获得和p75NTR特异结合的噬菌体 .测定DNA序列后得到有关多肽的氨基酸序列 .7肽库共有序列为C (H D)LP(K M)HPM C ;1 2肽库优势序列为TLPSPLALLTVH .化学合成相应的 2个短肽 .用细胞结合法和ELISA方法证实阳性噬菌体和合成短肽能与p75NTR结合 。 R2L1 cell line has been established by transfecting rat brain cell line (R2 cell line) with human low affinity neurotrophin receptor p75NTR. The apoptosis of R2L1 cells cultured with depriving serum can be inhibited by nerve growth factor (NGF). Peptide 12 mer phage display library and peptide 7 mer phage display library were used to panning against R2L1 cell line and R2 cell line. After three rounds panning, two dominant sequences were obtained: TLPSPLALLTVH(Ph.D 12), C (H/D)LP(K/M)HPM C (Ph.D 7). Two peptides were synthesized: C HLPKHPM C and RTLPSPLALLTVHD. Two amino acids were added at two sides of 12 mer peptide in order to enhance its solubility. Tests demonstrated that the positive phages and the chemically synthesized peptides could bind p75NTR by using ELISA method and cell binding method. The positive phages and the mimic short peptides action on R2L1 apoptosis was observed from the following two aspects: the morphological changes of cells by optical microscopy; the sub G1 peak in flow cytometric analysis. All of them can inhibit the apoptosis of R2L1 cells cultured with depriving of serum.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2003年第6期769-774,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金资助课题 (No .3 0 0 70 894)~~
关键词 神经生长因子低亲和力受体 神经生长因子 噬菌体展示肽库 氨基酸序列 low affinity neurotrophin receptor( p75NTR), nerve growth factor, phage display peptide library
  • 相关文献

参考文献9

  • 1[1]Raoul C, Pettmann B, Henderson C E. Active killing of neurons during development and following stress:a role for p75(NTR) and Fas? Curr Opin Neurobiol, 2000, 10(1): 111~117
  • 2[2]Montague J W, Cidlowski J A. Cellular catabolism in apoptosis: DNA degradation and endonuclease activation. Experientia,1996, 52: 957~962
  • 3[3]Lewin G R, Barde Y A. Physiology of the neurotrophins. Annu Rev Neurosci, 1996,19:289~317
  • 4[4]Liepinsh E., Iiag L L, Otting G, and Ibanez C F. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J, 1997,16: 4999~5005
  • 5[5]Hymowitz S G, Christinger H W, Fuh G, Ultsch M, O'Connell M, Kelly R F, Ashkenazi A, de Vos A M. Triggering cell death : crystal structure of Apo2L/TRAIL in complex with death receptor 5.Mol Cell, 1999, 4(4):563~571
  • 6[7]Goodson R J, Doyle M V, Kaufman S E, Rosenberg S. High-affinity urokinase receptor antagonists identified with bacteriophage peptide library. Proc Natl Acad Sci USA,1994,91:7129~7133
  • 7[8]Wrighton N C, Farrell F X, Chang R, Kashyap A K, Barbone F P, Mulcahy L S, Johnson D L, Barrett R W, Jolliffe L K, Dower W J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science,1996, 273:458~464
  • 8[9]Huang B R, Gu J J, Ming H, Lai D B, Zhou X F. Differential actions of neurotrophins on apoptosis mediated by the low affinity neurotrophin receptor p75NTR in immortalized neuronal cell line. Neurochem Int,2000,36(1):55~65
  • 9[11]Ryden M, Hemstead B, Ibanez C F. Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin factor. J Biol Chem, 1997, 272:16322~16328

同被引文献32

  • 1Maiese K, Li F, Chong Z Z. New avenues of exploration for erythropoietin. JAMA,2005, 293( 1 ) : 90-95.
  • 2Cervellini I, Bello E, Frapolli R, et al. The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats. Neurotox Res, 2010, 18(2) : 151- 160.
  • 3Campana W M, Misasi R, O' Brien J S. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med, 1998, 1 ( 1 ) :235-241.
  • 4Nagao M, Wen T C, Okamoto M, et al. In vivo neuroprotective activity of epopeptide AB against ischemic damage. Cytotechnology, 2005, 47 ( 1-3 ) : 139-144.
  • 5Cuello A C, Bruno M A, Allard S, et al. Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation. J Mol Neurosci, 2010, 40(1-2) :230-235.
  • 6Triaca V, Tirassa P, Aloe L. Presence of nerve growth factor and TrkA expression in the SVZ of EAE rats: evidence for possible functional significance. Exp Neurol, 2005, 191 ( 1 ) : 63-64.
  • 7Huang B R, Gu J J, Ming H, et al. Differential actions of neurotrophins on apoptosis mediated by the low affinity neurotrophin receptor p75NTR in immortalized neuronal cell lines. Neurochem Int, 2000, 36( 1 ) :55-65.
  • 8Brines M L, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA, 2000, 97(19) :10526-10531.
  • 9Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med, 2002, 8 ( 8 ) : 495-505.
  • 10Tam J, Diamond J, Maysinger D. Dual-action peptides: a new strategy in the treatment of diabetes-associated neuropathy. Drag Discov Today, 2006, 11 (5-6) : 254-260.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部